blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0330468

EP0330468 - Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.01.1992
Database last updated on 02.11.2024
Most recent event   Tooltip02.01.1992Application deemed to be withdrawnpublished on 19.02.1992 [1992/08]
Applicant(s)For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
[N/P]
Former [1989/35]For all designated states
GLAXO GROUP LIMITED
Clarges House 6-12 Clarges Street
London W1Y 8DH / GB
Inventor(s)01 / Hayes, Ann Gail
5 Sandringham Road
Potters Bar Hertfordshire / GB
[1989/35]
Representative(s)Pett, Christopher Phineas, et al
Dehns
St Bride's House
10 Salisbury Square
London
EC4Y 8JD / GB
[N/P]
Former [1989/35]Pett, Christopher Phineas, et al
Frank B.Dehn & Co. Imperial House 15-19 Kingsway
London WC2B 6UZ / GB
Application number, filing date89301772.323.02.1989
[1989/35]
Priority number, dateGB1988000410623.02.1988         Original published format: GB 8804106
GB1988000410923.02.1988         Original published format: GB 8804109
GB1988000411023.02.1988         Original published format: GB 8804110
GB1988001217323.05.1988         Original published format: GB 8812173
[1989/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0330468
Date:30.08.1989
Language:EN
[1989/35]
Type: A3 Search report 
No.:EP0330468
Date:03.04.1991
Language:EN
[1991/14]
Search report(s)(Supplementary) European search report - dispatched on:EP14.02.1991
ClassificationIPC:A61K31/395, A61K31/40, A61K31/445, A61K31/55, A61K31/47, C07D211/26, C07D211/70
[1989/35]
CPC:
A61K31/47 (EP); A61K31/395 (EP,US); A61K31/40 (EP);
A61K31/445 (EP); A61K31/55 (EP); A61P25/28 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07D211/26 (EP);
C07D211/70 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   IT,   LI,   NL,   SE [1989/35]
TitleGerman:Verwendung von heterocyclischen Derivaten als kappa-Opiat-Rezeptoragonisten zur Behandlung der zerebralen Ischämie[1989/35]
English:Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia[1989/35]
French:Utilisation de dérivés hétérocycliques comme agonistes des récepteurs kappa aux opioides dans le traitement de l'ischémie cérébrale[1989/35]
File destroyed:15.03.1999
Examination procedure29.08.1991Application deemed to be withdrawn, date of legal effect  [1992/08]
24.09.1991Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1992/08]
Fees paidPenalty fee
Additional fee for renewal fee
28.02.199103   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]AU66824B  ;
 [A]US4304911  (ZENITZ BERNARD L);
 [YD]EP0176309  (UPJOHN CO [US]);
 [YD]EP0233793  (ROUSSEL UCLAF [FR]);
 [YD]EP0260041  (ZAMBELETTI SPA L [IT])
 [Y]  - Life Sciences, Vol. 37, No. 16, 1985, pages 1475-1482, Pergamon Press LTD, US, A.H. TANG: "Protection from cerebral ischemia by U-50, 488E, a specific kappa opioid analgesic agent"page 1481.
 [Y]  - Brain Research, Vol. 403, No. 1, 1987, pages 52-57, Elsevier Science Publ. B.V., R.C. SILVIA et al.: "Protection from ischemia-induced cerebral edema in the rat by U-50488Ha kappa opioid receptor agonist"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.